Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 13, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

958

Ependymoma.

Elizabeth R Gerstner1, Kristian W Pajtler2,3,4

  • 1Division of Neuro-oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.

Seminars in Neurology
|March 17, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRACED: In vivo imaging of extracellular intrinsic diffusivity, tortuosity, cell size distribution and cell density in human glioma patients.

ArXiv·2026
Same author

Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors.

JCO precision oncology·2026
Same author

Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Nature·2026
Same author

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

Neuro-oncology advances·2026
Same author

Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.

Scientific reports·2026
Same author

Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Nature·2026
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Molecular classification is improving the understanding and treatment of ependymoma, a rare brain tumor. This approach better reflects tumor biology than traditional methods, aiding future risk stratification and targeted therapies.

Area of Science:

  • Neuro-oncology
  • Molecular Pathology
  • Genomics

Background:

  • Ependymoma occurs throughout the neuraxis, with varied locations in children and adults.
  • Histopathological classification of ependymoma (grade II vs. III) shows limited clinical utility due to significant variance.
  • Molecular profiling reveals distinct ependymoma groups, addressing biological and clinical heterogeneity.

Purpose of the Study:

  • To highlight the limitations of traditional histopathological classification for ependymoma.
  • To emphasize the role of epigenomic profiling in identifying distinct molecular groups.
  • To discuss the integration of molecular classification into future clinical trials for improved risk stratification.

Main Methods:

  • Epigenomic profiling of ependymoma tumors.

More Related Videos

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

10.3K

Related Experiment Videos

Last Updated: Feb 13, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

958
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

10.3K
  • Analysis of molecular, clinical, and histopathological data.
  • Review of current World Health Organization classification updates.

    • Main Results:

    • Molecular classification identifies distinct ependymoma groups that correlate with biological, clinical, and histopathological differences.
    • One molecular group has been integrated into the latest WHO classification of central nervous system tumors.
    • Genetic drivers for most molecular ependymoma groups remain unknown, necessitating further research.

    Conclusions:

    • Molecular classification offers a more robust framework for understanding ependymoma heterogeneity.
    • Future clinical trials will incorporate molecular classification for enhanced risk stratification.
    • Target discovery for ependymoma requires novel research strategies due to unknown genetic drivers in many subtypes.